Pharma and BioTech Daily

De: Pharma and BioTech News
Escúchala gratis

  • Resumen

  • This podcast aims to bring you a daily summary of the most relevant news in Pharma and BioTech. Check our website at: https://www.buzzsprout.com/2189790
    © 2025 Pharma and BioTech Daily
    Más Menos
Política y Gobierno
Más Menos
Episodios
  • Pharma and Biotech Daily: CRISPR Breakthroughs, FDA Concerns, and Vaccine Controversies

    Pharma and Biotech Daily: CRISPR Breakthroughs, FDA Concerns, and Vaccine Controversies
    May 6 2025
    Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.Two companies, Beam Therapeutics and Verve Therapeutics, have developed lead candidates using a safer alternative to conventional CRISPR called base editing. Clinical results have been promising. FDA insiders are calling on FDA Commissioner Marty Makary to fight against agency politicization. The Trump administration, including HHS Secretary Robert F. Kennedy Jr., is accused of distorting and denying scientific truths and potentially censoring information.FDA action alerts include expansion bids for drugs by GSK and Merck. A new AI-powered solution called Generative AIPTP helps life sciences firms streamline clinical workflows. The FDA is rehiring travel staff as lapses begin to show.RFK Jr. is driving a wedge into vaccine conversations. WHO may add obesity drugs for adults to the essential medicines list. Various companies like Merck, GSK, and Roche present key data at AACR 2025.HHS will require placebo-controlled trials for all new vaccines in a radical departure from past practices. Tariffs dominate Q1 earnings, AACR excites the cancer space, CEO pay gaps are discussed, and more news and events are highlighted.
    Más Menos
    1 m
  • Pharma and Biotech News Roundup: Tax Policy vs Tariffs, FDA Rehiring Travel Staff, and Custom mRNA Sets

    Pharma and Biotech News Roundup: Tax Policy vs Tariffs, FDA Rehiring Travel Staff, and Custom mRNA Sets
    May 5 2025
    Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world. Amgen, along with other big pharma companies, is advocating for a "pro-growth tax policy" over tariffs to boost domestic pharmaceutical manufacturing. They are urging the Trump administration to consider tax policy as a better alternative. A report suggests that low-price drug nations are benefiting from US innovation, FDA is rehiring travel staff, and there are concerns about censorship of scientific truths by RFK Jr. Trilink Biotechnologies has introduced custom sets of mRNA for screening studies. Updates include potential additions of obesity drugs to essential medicines list, company buyouts, layoffs in the industry, and upcoming events and job opportunities in the biotech sector.
    Más Menos
    1 m
  • Pharma and Biotech Daily: Lilly's Revenue Soars, Moderna Cuts Costs, and HHS Implements New Vaccine Trial Policy

    Pharma and Biotech Daily: Lilly's Revenue Soars, Moderna Cuts Costs, and HHS Implements New Vaccine Trial Policy
    May 2 2025
    Good morning from Pharma and Biotech Daily: the podcast that gives you only what's important to hear in Pharma and Biotech world. Lilly's revenue jumped by 45% in the latest quarter, driven by the success of their drugs Zepbound and Mounjaro. Moderna missed revenue expectations for the first quarter but plans to cut $1.5 billion in costs. Biogen executives are dealing with tariffs, but believe the impact will be minimal. The Department of Health and Human Services announced a new policy requiring placebo-controlled trials for all new vaccines, which has been met with criticism from experts. Trilink Biotechnologies has introduced custom sets of mRNA for screening studies. In other news, CVS has chosen Novo's side in the obesity market battle, RFK Jr. is sparking controversy in vaccine discussions, and J&J has entered the myasthenia gravis market. Additionally, AstraZeneca faced a setback with their drug Truqap in a phase III prostate cancer study.
    Más Menos
    1 m
adbl_web_global_use_to_activate_webcro805_stickypopup

Lo que los oyentes dicen sobre Pharma and BioTech Daily

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.

Reseñas de Audible.com

Opiniones de Amazon
No hay comentarios disponibles